RhumbLine Advisers’s Kite Pharma, Inc. KITE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-59,331
| Closed | -$10.7M | – | 2897 |
|
|
2017
Q3 | $10.7M | Buy |
59,331
+3,771
| +7% | +$678K | 0.02% | 640 |
|
|
2017
Q2 | $5.76M | Buy |
55,560
+8,466
| +18% | +$878K | 0.01% | 921 |
|
|
2017
Q1 | $3.7M | Buy |
47,094
+2,375
| +5% | +$186K | 0.01% | 1195 |
|
|
2016
Q4 | $2.01M | Buy |
44,719
+2,780
| +7% | +$125K | 0.01% | 1452 |
|
|
2016
Q3 | $2.34M | Buy |
41,939
+2,991
| +8% | +$167K | 0.01% | 1302 |
|
|
2016
Q2 | $1.95M | Buy |
38,948
+6,365
| +20% | +$318K | 0.01% | 1363 |
|
|
2016
Q1 | $1.5M | Buy |
32,583
+3,815
| +13% | +$175K | ﹤0.01% | 1561 |
|
|
2015
Q4 | $1.77M | Buy |
28,768
+2,660
| +10% | +$164K | 0.01% | 1436 |
|
|
2015
Q3 | $1.45M | Buy |
26,108
+993
| +4% | +$55.3K | ﹤0.01% | 1539 |
|
|
2015
Q2 | $1.53M | Buy |
25,115
+15,655
| +165% | +$954K | ﹤0.01% | 1597 |
|
|
2015
Q1 | $546K | Buy |
9,460
+2,525
| +36% | +$146K | ﹤0.01% | 2253 |
|
|
2014
Q4 | $400K | Buy |
+6,935
| New | +$400K | ﹤0.01% | 2408 |
|